D-Street Newsmakers: Amber Enterprises, India Cements and Shriram Finance among 7 stocks that hogged limelight today

Equity benchmarks in a volatile session ended Monday's session higher tracking global cues- snapping a 5-day losing streak. At the close, Sensex ended higher by 0.64 per cent or 498.5 points at 78,540, while the Nifty50 gained 0.7 per cent to close above 23,750 levels. 

Barring, auto and media all sectoral indices witnessed buying action today after steep losses in the past week.

Vinod Nair, Head of Research, Geojit Financial Services said, "The Indian market demonstrated optimism following the recent sell-off. The lower-than-expected US PCE print bolstered investor sentiment in interest rate-sensitive sectors. Broad-based buying was observed, with the metals sector notably benefiting from the anticipated increase in steel import taxes."

 Despite the positive market sentiment, the short-term outlook is expected to remain sideways due to a lack of new catalysts and the impact of the festive season and holidays, added Nair.

Here are the stocks that remained in spot light:

India Cements:

The stock ended with gains of over 8 per cent at Rs 366.15 per share as the CCI gave nod to the acquisition of a majority stake in the company to UltraTech Cement.

Mazagon Dock Shipbuilders:

Shares of the PSU ended in the red after gaining over 2 per cent in intraday trade. The early gains in the stock came as the defence major delivered two of the warships to Indian Navy.

Amber Enterprises:

Amid a sharp spurt in trading volume on the counter, the stock ended higher by 13 per cent at Rs 6,891.1 per share.

Shriram Finance:

This Nifty50 stock ended with gains of 0.4 per cent at Rs 2,883 after the company fixed January 10 as the record date for share split.

Aster DM Healthcare:

The stock ended over 3 per cent higher at Rs 503.45 amid sharp uptick in trading volume. Also, the company on the sidelines announced a change in management.

Aurobindo Pharma:

Aurobindo Pharma scrip settled over 1 per cent higher at Rs 1,253.3 as  the company announced that CuraTeQ Biologics s.r.o., a step-down subsidiary of Aurobindo Pharma, is in receipt of marketing authorisation from UK’s Medicines and Healthcare products Regulatory Agency (MHRA) for Bevqolva.

Siemens:

Siemens shares ended with a cut of over 0.5 per cent at Rs 6,831.15 even as UBS maintained its 'neutral' stance on the counter with the target pegged at Rs 8,000 per share.